Lawton Alison Frances 4
4 · Aeglea BioTherapeutics, Inc. · Filed Dec 17, 2020
Insider Transaction Report
Form 4
LAWTON ALISON FRANCIS
Director
Transactions
- Award
Director Stock Option (right to buy)
2020-12-15+47,200→ 47,200 totalExercise: $9.09Exp: 2030-12-14→ Common Stock (47,200 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable in 36 equal monthly installments beginning on January 15, 2021 until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.